IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v16y2025i1d10.1038_s41467-025-56396-7.html
   My bibliography  Save this article

Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies

Author

Listed:
  • Mathieu Ferrari

    (Autolus Therapeutics)

  • Farhaan Parekh

    (Autolus Therapeutics)

  • Paul Maciocia

    (University College London)

  • Pedro Horna

    (Mayo Clinic)

  • Simon Thomas

    (Autolus Therapeutics)

  • Andrew K. Sewell

    (Cardiff University School of Medicine
    Cardiff University)

  • Martin Pule

    (Autolus Therapeutics
    University College London)

Abstract

No abstract is available for this item.

Suggested Citation

  • Mathieu Ferrari & Farhaan Parekh & Paul Maciocia & Pedro Horna & Simon Thomas & Andrew K. Sewell & Martin Pule, 2025. "Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies," Nature Communications, Nature, vol. 16(1), pages 1-4, December.
    • Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-56396-7
    DOI: 10.1038/s41467-025-56396-7
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-025-56396-7
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-025-56396-7?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Mathieu Ferrari & Matteo Righi & Vania Baldan & Patrycja Wawrzyniecka & Anna Bulek & Alexander Kinna & Biao Ma & Reyisa Bughda & Zulaikha Akbar & Saket Srivastava & Isaac Gannon & Mathew Robson & Jame, 2024. "Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    2. Xiangjun Liu & Shanzhao Jin & Simeng Hu & Ruoyan Li & Haihao Pan & Yi Liu & Pan Lai & Deshu Xu & Jingru Sun & Ziyang Liu & Yumei Gao & Yifan Zhao & Fengjie Liu & Yu Xiao & Yingyi Li & Yujie Wen & Zhuo, 2022. "Single-cell transcriptomics links malignant T cells to the tumor immune landscape in cutaneous T cell lymphoma," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
    3. Tushar D. Nichakawade & Jiaxin Ge & Brian J. Mog & Bum Seok Lee & Alexander H. Pearlman & Michael S. Hwang & Sarah R. DiNapoli & Nicolas Wyhs & Nikita Marcou & Stephanie Glavaris & Maximilian F. Konig, 2024. "TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers," Nature, Nature, vol. 628(8007), pages 416-423, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Benjamin Thiele & Paul Schmidt-Barbo & Christoph Schultheiss & Edith Willscher & Thomas Weber & Mascha Binder, 2025. "Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies," Nature Communications, Nature, vol. 16(1), pages 1-4, December.
    2. Weili Ma & Maria Cecília Oliveira-Nunes & Ke Xu & Andrew Kossenkov & Benjamin C. Reiner & Richard C. Crist & James Hayden & Qing Chen, 2023. "Type I interferon response in astrocytes promotes brain metastasis by enhancing monocytic myeloid cell recruitment," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    3. Yun-Tsan Chang & Pacôme Prompsy & Susanne Kimeswenger & Yi-Chien Tsai & Desislava Ignatova & Olesya Pavlova & Christoph Iselin & Lars E. French & Mitchell P. Levesque & François Kuonen & Malgorzata Bo, 2024. "MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    4. Chen-Hui Luo & Li-Hong Hu & Jie-Yang Liu & Li Xia & Li Zhou & Ren-Hong Sun & Chen-Cen Lin & Xing Qiu & Biao Jiang & Meng-Ying Yang & Xue-Hong Zhang & Xiao-Bao Yang & Guo-Qiang Chen & Ying Lu, 2024. "CDK9 recruits HUWE1 to degrade RARα and offers therapeutic opportunities for cutaneous T-cell lymphoma," Nature Communications, Nature, vol. 15(1), pages 1-23, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-56396-7. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.